期刊文献+

依那普利叶酸片联合麝香保心丸对行急诊PCI的STEMI病人血浆炎性指标及心脏功能的影响 被引量:10

The Influence of Enalapril Folic Acid Tablets Plus Shexiang Baoxin Pills on the Plasma Inflammatory Markers and Cardiac Function in Patients with STEMI Undergoing Emergency PCI
下载PDF
导出
摘要 目的探讨依那普利叶酸片联合麝香保心丸对行急诊经皮冠状动脉介入术(PCI)的ST段抬高型心肌梗死(STEMI)病人炎性指标和心功能的影响。方法选取2016年1月—2017年7月入院的STEMI且行急诊PCI的病人70例,随机分为马来酸依那普利组(对照组)和马来酸依那普利叶酸片联合麝香保心丸组(试验组),各35例。分别评价两组病人住院时及治疗3个月后超敏C反应蛋白(hs-CRP)、血浆中N末端脑钠肽前体(NT-proBNP)、血浆同型半胱氨酸(Hcy)、左室射血分数(LVEF)、左室舒张末期内径(LVEDD)等指标。结果两组病人入院时基线资料相匹配(P>0.05)。治疗3个月后,试验组血浆Hcy水平明显低于入院时水平,且明显低于对照组(P<0.05)。两组血浆hs-CRP均明显降低(P<0.05),试验组明显低于对照组(P<0.05)。两组病人LVEF均较入院时明显升高,LVEDD明显降低,有统计学意义(P<0.05),两组间比较亦有统计学意义(P<0.05)。结论马来酸依那普利叶酸片联合麝香保心丸能有效降低行急诊PCI术的STEMI病人血浆Hcy、CRP水平,并可改善心功能。 Objective To investigate the effects of enalapril folic acid tablets plus Shexiang Baoxin pills( SBP) on inflammatory markers and cardiac function in patients with ST-elevation myocardial infarction( STEMI) undergoing emergency percutaneous coronary intervention( PCI).Methods Seventy patients with STEMI undergoing emergency PCI were collected from January 2016 to July 2017.All patients were randomly divided into two groups: control group( n = 35) treated with enalapril folic acid tablets,and treatment group( n = 35) treated with enalapril folic acid tablets plus SBP for 3 months.The concentrations of plasma high sensitive C-reactive protein( hs-CRP),N-terminal probrain natriuretic peptide( NT-proBNP),homocysteine( Hcy),and left ventricular ejection fraction( LVEF),left ventricular end-diastolic diameter( LVEDD) were assessed on admission and 3 months after treatment.Results After 3 months of treatment,the Hcy concentration in treatment group was lower than that in control group as well as that on admission( P〈0.05).The hs-CRP concentration reduced significantly in two groups( P〈0.05),which was lower in treatment group than that in control group( P〈0.05).Compared with those on admission,the LVEF increased and LVEDD decreased in two groups( P〈0.05).In addition,there were significant differences in the LVEF and LVEDD between two groups( P〈0.05).Conclusion Enalapril folic acid tablets plus SBP can effectively reduce the plasma levels of Hcy,hs-CRP,and improve cardiac function in patients with STEMI undergoing emergency PCI.
作者 陈保增 冯明静 常方圆 孙泽刚 张云 冯泽瑞 许迎春 王云鹏 叶岩岩 齐玉军 李慧杰 Chen Baozeng;Feng Mingjing;Chang Fangyuan;Sun Zegang;Zhang Yun;Feng Zerui;Xu Yingchun;Wang Yunpeng;Ye Yanyan;Qi Yujun;Li Huijie(Liaocheng Second People's Hospital Affiliated to Taishan Medical University,Liaocheng 252600,Shandong,Chin)
出处 《中西医结合心脑血管病杂志》 2018年第12期1687-1690,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 急性心肌梗死 ST段抬高型心肌梗死 经皮冠状动脉介入 依那普利叶酸片 麝香保心丸 同型半胱氨酸 N端脑钠肽前体 acute myocardial infarction ST elevation myocardial infarction percutaneous coronary intervention enalapril folic acidtablets Shexiang Baoxin pills homocysteine N terminal pro brain natriuretic peptide
  • 相关文献

参考文献5

二级参考文献44

  • 1张素荣,陈志刚,吕风华,张永春,李红军,袁宇,黄陆力,张卫国.不同剂量叶酸、B族维生素对冠心病患者血浆同型半胱氨酸的影响[J].中国心血管病研究,2006,4(7):493-494. 被引量:7
  • 2丁旭东,张贵斌,叶琳,肖红琼,罗韵文,黄本友,梅元武.血浆同型半胱氨酸与缺血性进展性脑卒中的相关研究[J].疑难病杂志,2007,6(2):73-76. 被引量:16
  • 3Hung MJ,Cherng WJ,Cheng CW,et al.Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease[J].Am J Cardiol,2006;97(10):1429-34.
  • 4Rocchi E,Bursi F,Ventura P,et al.Anti-and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease[J].Eur J Intern Med,2007;18(4):314-20.
  • 5Arroyo-Espliguero R,Avanzas P,Quiles J,et al.C-reactive protein predicts functional status and correlates with left ventricular ejection fraction in patients with chronic stable angina[J].Atherosclerosis,2009;205(1):319-24.
  • 6Wang Y,Li L,Tan HW,et al.Transcoronary concentration gradient of s CD40L and hs CRP in patients with coronary heart disease[J].Clin Cardiol,2007;30(2):86-91.
  • 7Jones RD,Nettleship JE,Kapoor D,et al.Testosterone and atherosclerosis in aging men:purported association and clinical implications[J].Am J Cardiovasc Drugs:drugs,2005;5(3):141-54.
  • 8Deedwania P.Selective and specific inhibition of if with ivabradine for th treatment of coronary artery disease or heart failure[J].Drugs,2013;7(14):1569-86.
  • 9Malacco E,Santonastaso M,Var NA,et al .Comparison of valsartan160 mg with lisinopril 20 mg,given as monotherapy or incombination with a diuretic,for the treatment of hypertension:the Blood Pressure Reduction and Tolerability of Valsartan inComparison with Lisinopril(PREVAIL)study[J].Clin Ther,2004,26(6):855-865.
  • 10苏保鑫,李淑翠,王贵年,刘继涛,陈群.同型半胱氨酸和总胆红素及高敏C反应蛋白水平与冠心病临床分型相关性研究[J].中国医药,2009,4(12):968-970. 被引量:30

共引文献111

同被引文献129

引证文献10

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部